Clinical trial Recruiting at 1 site Interventional Ages 35 to 75 Women only

Effects of HIIT vs Strength Training on Health in Postmenopausal Women with Breast Cancer

Official title: Postmenopausal Oncological Women Exercising for Recover Their Health. Associations and Changes in Metabolic Flexibility and Autonomic Control After Two Training Programs (Muscle Power vs Metabolic Power): the POWER Health Study

Run by University of Valencia · NCT06336070 · Data updated 2026-11-12

This study is testing whether high-intensity interval training or strength training can improve heart health and overall well-being in postmenopausal women who have had breast cancer.

More Breast Cancer Female trials

Quick facts

Study typeInterventional
Ages35 Years to 75 Years
SexWomen only
Enrollment56 (estimated)
SponsorUniversity of Valencia
Academic / other
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedJanuary 1, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2028
Registry record updatedApril 4, 2024
Trial IDNCT06336070 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include postmenopausal women aged 35 to 75 who are either relapse-free from breast cancer or have not been diagnosed with cancer in the last 15 years.

Probably not a fit

Patients with medical contraindications to exercise or those who have planned surgeries during the intervention period may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The POWER Health study is a randomized clinical trial designed to evaluate metabolic flexibility and autonomic function in postmenopausal women with a history of breast cancer compared to untreated controls. Participants will undergo two different 8-week supervised exercise interventions: high-intensity interval training (HIIT) aimed at improving metabolic power and strength training focused on enhancing muscle power. The study aims to determine the impact of these interventions on cardiovascular health and overall well-being in this population. By comparing these two approaches, the trial seeks to identify the most effective exercise regimen for improving health outcomes in postmenopausal oncological women.

Why it matters

Potential benefit: If successful, this study could lead to improved cardiovascular health and quality of life for postmenopausal women with a history of breast cancer.

How similar studies have gone: Previous studies have shown positive outcomes with exercise interventions in cancer survivors, suggesting that this approach may be beneficial, although the specific comparison of HIIT and strength training in this context is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed of relapse free-cancer (RFC) or patients not diagnosed of any cancer at least the last 15 years (CG)
* Aged between 35 and 75 years
* Diagnostic of breast cancer (i.e., including ductal carcinoma, invasive carcinoma, triple negative; RFC) or physiological menopause (CG)
* Not participating in a nutritional/dietary intervention
* Not being physically active (i.e., not to be participating in any physical exercise program in the last 3 months, or performing less than 600 metabolic equivalents (METS)/week of moderate-vigorous physical activity).
* To be capable and willing to provide informed consent
* Not to suffer from any specific condition that may impede testing of the study hypothesis or make it unsafe to engage in the exercise intervention (i.e., determined by the research staff).

Exclusion Criteria:

* Medical contraindication for being engaged in an exercise.
* Additional surgery planned within the intervention
* Consuming usually betablocker or any drugs alterning nervous system functioning
* History of another primary invasive cancer (RFC) or suffer a serious chronic illness (CG)
* To present any of the following cardiac conditions: (i) myocardial infarction or coronary revascularization procedure within prior 3 months, (ii) uncontrolled hypertension (i.e., systolic ≥180 mmHg or diastolic ≥100 mmHg), (iii) uncontrolled arrhythmias (iv) valvular disease clinically significant, (v) decompensated heart failure or (vi) to suffer from known aortic aneurysm.

Where it's running

  • Faculty of Physical Activity and Sport Sciences
    Valencia, Valencia, Spain
    Recruiting

Study contacts

  • Principal investigator: Cristina Blasco Lafarga, Tenured Professor — University of Valencia
  • Study coordinator: Cristina Blasco Lafarga, Tenured Professor
  • Email: m.cristina.blasco@uv.es
  • Phone: 64372

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.